发明名称 |
Monoclinic crystalline form of asenapine maleate with a specific particle size distribution |
摘要 |
A monoclinic crystalline form of asenapine maleate is described, which is characterized in that it is not micronised and has a particle size distribution characterized by a d90 of 40 μm or less. A process for the preparation of a monoclinic crystalline form of asenapine maleate is also described, the process comprising the following steps: a) providing a mixture of monoclinic asenapine maleate and an organic solvent which, under the conditions of the process, acts as an antisolvent; b) stirring the mixture at a temperature between 15 and 60° C.; and c) collecting the crystals, wherein the organic solvent is selected from alcohols, ketones, ethers, esters, hydrocarbons or mixtures thereof. |
申请公布号 |
US9533994(B2) |
申请公布日期 |
2017.01.03 |
申请号 |
US201214118483 |
申请日期 |
2012.05.18 |
申请人 |
Laboratorios Lesvi S.L. |
发明人 |
Solà Carandell Lluis;Cerón Bertran Jordi;Freixas Pascual Glòria;Dalmases Pere |
分类号 |
C07D491/04;C07D491/044;A61K31/407 |
主分类号 |
C07D491/04 |
代理机构 |
Stites & Harbison, PLLC |
代理人 |
Stites & Harbison, PLLC ;Wright Terry L. |
主权项 |
1. A monoclinic crystalline form of asenapine maleate characterized in that it is not micronized, has a polymorphic purity of more than 90%, and has a particle size distribution characterized by a d90 of 31 μm or less, preferably of 16 μm or less. |
地址 |
Barcelona ES |